Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIPS penicillin concentration challenge trial for prevention of Strep A pharyngitis
ACTRN12621000751875Phase 2Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benzylpenicillin and azithromycin in streptococcal pharyngitis and Streptococcus pyogenes infection (5 arms), sponsored by Kids Research Institute Australia. Primary endpoint: Acute symptomatic Streptococcus pyogenes pharyngitis. Started Aug 2022; status: completed.
02
Drugs
benzylpenicillinazithromycin
03
Conditions
streptococcal pharyngitisStreptococcus pyogenes infection
Beyond the preview
Go deeper on ACTRN12621000751875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000751875.